(Q35653969)

English

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

scientific article published on 10 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

K Mazzocco

24

0 references

object named as

A Cañete

19

0 references

Isabelle Janoueix-Lerosey

object named as

I Janoueix-Lerosey

11

0 references

Victoria Castel

object named as

V Castel

20

0 references

object named as

P Ambros

32

0 references

Olivier Delattre

34

object named as

O Delattre

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

9

object named as

N Auger

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Deborah A Tweddle

13

object named as

D A Tweddle

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Andrew D. J. Pearson

12

object named as

A Pearson

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

object named as

J Michon

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Ruth Ladenstein

30

object named as

R Ladenstein

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

G Schleiermacher

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A Ribeiro

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

G Pierron

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

V Mosseri

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

H Rubie

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

C Munzer

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J Bénard

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

V Combaret

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

N Bown

14

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

M Gerrard

15

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

K Wheeler

16

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

R Noguera

17

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

E Villamon

18

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

B Marques

21

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A de Lacerda

22

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

G P Tonini

23

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

R Defferrari

25

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

B de Bernardi

26

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A di Cataldo

27

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

N van Roy

28

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

B Brichard

29

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

I Ambros

31

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

K Beiske

33

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

J Couturier

35

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

10 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1940-1948

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

A multilocus technique for risk evaluation of patients with neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Molecular pathogenesis of peripheral neuroblastic tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Copy number variation at 1q21.1 associated with neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Overall genomic pattern is a predictor of outcome in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Chromosome 1p and 11q deletions and outcome in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Prognostic significance of DNA di-tetraploidy in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

12 July 2018

Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.472

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.472

21 January 2018

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.472

21 January 2018

Recent advances in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3251887

25 September 2018

Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.472

21 January 2018

Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22146831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22146831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22146831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22146831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97

1 reference

https://pubmed.ncbi.nlm.nih.gov/22146831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accumulation of Segmental Alterations Determines Progression in Neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22146831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2011.472

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35653969&oldid=2197582437"